Real-time enrollment status for this chronic kidney disease clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:11 PM UTC
| NCT Number | NCT05196035 |
| Recruiting Status | Recruiting |
| Condition | Chronic Kidney Disease |
| Phase | PHASE3 |
| Target Enrollment | 219 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Bayer |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT05196035 is currently recruiting participants. This phase3 study for chronic kidney disease is actively seeking new participants at 19 locations across the United States. The study is sponsored by Bayer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05196035 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05196035 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.